| Study of 72-Hour Infusion of ON 01910.Na in Patients With MDS or AML (NCT00854945) | Traws Pharma, Inc. | 2009-01-01 |
| Lenalidomide In Patients With Acute Myeloid Leukemia (NCT00839059) | University of Ulm | 2009-01-01 |
| RAD001 in Combination With PKC412 in Patients With Relapsed, Refractory or Poor Prognosis AML or MDS (NCT00819546) | Richard Stone, MD | 2009-01-01 |
| Invasives Aspergillosis in Acute Myeloid Leukemia (NCT02900430) | University Hospital, Brest | 2009-01-01 |
| Azacitidine and Gemtuzumab Ozogamicin in Treating Older Patients With Previously Untreated Acute Myeloid Leukemia (NCT00658814) | National Cancer Institute (NCI) | 2008-12-01 |
| Clinical Phase III Trial Treosulfan-based Conditioning Versus Reduced-intensity Conditioning (RIC) (NCT00822393) | medac GmbH | 2008-11-24 |
| Vaccination With GM-K562 Cells in Patients With Advanced Myelodysplastic Syndrome (MDS) or Acute Myeloid Leukemia (AML) After Allogeneic Hematopoetic Stem Cell Transplantation (NCT00809250) | Dana-Farber Cancer Institute | 2008-11-01 |
| Bendamustine in Acute Leukemia and MDS (NCT00790855) | M.D. Anderson Cancer Center | 2008-11-01 |
| Safety Study of 5-Azacitidine and Standard Donor Lymphocyte Infusion (DLI) to Treat Acute Myeloid Leukemia (AML) or Myelodysplastic Syndrome (MDS) Relapsing After Allogeneic Stem Cell Transplantation (NCT00795548) | Heinrich-Heine University, Duesseldorf | 2008-11-01 |
| Fludarabine Phosphate, Cyclophosphamide, Total-Body Irradiation, and Donor Bone Marrow Transplant Followed by Donor Natural Killer Cell Therapy, Mycophenolate Mofetil, and Tacrolimus in Treating Patients With Hematologic Cancer (NCT00789776) | Fred Hutchinson Cancer Center | 2008-10-13 |
| A Study of a Home-based Exercise Intervention for Patients With Acute Myeloid Leukaemia (AML) (NCT00764231) | Toronto Rehabilitation Institute | 2008-10-01 |
| Clofarabine Plus Low-Dose Cytarabine Induction and Decitabine Consolidation in Frontline Acute Myeloid Leukemia (AML) and High-Risk Myelodysplastic Syndrome (MDS) (NCT00778375) | M.D. Anderson Cancer Center | 2008-10-01 |
| Collection and Banking of Leukemia Cells MDS/AML (NCT00809367) | Dana-Farber Cancer Institute | 2008-10-01 |
| Trial of CPX-351 in Newly Diagnosed Elderly AML Patients (NCT00788892) | Jazz Pharmaceuticals | 2008-10-01 |
| Phase I/II Study of Mitoxantrone, Etoposide and Gemtuzumab Ozogamicin for Acute Myeloid Leukemia (NCT00660036) | University of Pittsburgh | 2008-09-01 |
| Bortezomib, Daunorubicin, and Cytarabine in Treating Older Patients With Previously Untreated Acute Myeloid Leukemia (NCT00742625) | National Cancer Institute (NCI) | 2008-09-01 |
| Safety & Pharmacokinetics Study Of Azacitidine (SC And Oral) In Subjects With MDS, CMML, AML, Lymphoma And Multiple Myeloma (NCT00761722) | Celgene | 2008-08-12 |
| Clofarabine Plus Cytarabine Versus Conventional Induction Therapy And A Study Of NK Cell Transplantation In Newly Diagnosed Acute Myeloid Leukemia (NCT00703820) | St. Jude Children's Research Hospital | 2008-08-04 |
| Deferoxamine for Iron Overload Before Allogeneic Stem Cell Transplantation (NCT00658411) | Dana-Farber Cancer Institute | 2008-08-01 |
| Study of LY573636-sodium in Essential Thrombocythemia and Acute Myeloid Leukemia (NCT00718159) | Eli Lilly and Company | 2008-08-01 |
| Clinical Study of SU 11248 (Sutent) Combined With Standard Chemotherapy in Patients With FLT3 Mutated AML Over 60 Years (NCT00783653) | Universitätsklinikum Hamburg-Eppendorf | 2008-08-01 |
| Reduced Intensity Total Body Irradiation + Thymoglobulin Followed by Allogeneic PBSCT (NCT00709592) | Virginia Commonwealth University | 2008-07-21 |
| Trial With Azacitidine in Newly Diagnosed Acute Myelogenous Leukemia (AML) Veterans Administration (VA) Elderly Patients Not Eligible for Standard Induction Therapy (NCT00728520) | Kansas City Veteran Affairs Medical Center | 2008-07-01 |
| Donor Umbilical Cord Blood Transplant in Treating Patients With Hematologic Cancer (NCT00723099) | Fred Hutchinson Cancer Center | 2008-06-25 |
| Reduced Intensity Conditioning With Clofarabine, Antithymocyte Globulin (ATG), Total Lymphoid Irradiation (TLI) Followed by Allogeneic Stem Cell Transplant (NCT00697684) | Beth Israel Deaconess Medical Center | 2008-06-01 |
| Maintenance Therapy in Acute Myeloid Leukemia (AML) Patients (NCT00957385) | University Health Network, Toronto | 2008-06-01 |
| Study of Voreloxin (Vosaroxin) in Older Patients With Untreated Acute Myeloid Leukemia (NCT00607997) | Sunesis Pharmaceuticals | 2008-05-15 |
| INCB018424 in Patients With Advanced Hematologic Malignancies (NCT00674479) | M.D. Anderson Cancer Center | 2008-05-12 |
| Velcaflagida in Relapsed or Refractary Acute Myeloid Leukemia (NCT00651781) | PETHEMA Foundation | 2008-04-01 |
| Prevention of Left Ventricular Dysfunction During Chemotherapy (NCT01110824) | Hospital Clinic of Barcelona | 2008-04-01 |
| Development and Exploration of the Feasibility of Using Locally Synthesized Small Molecule Inhibitors to Treat Human Acute Leukemia Cells (NCT01142375) | Taipei Medical University WanFang Hospital | 2008-04-01 |
| A Study of ARRY-520 in Patients With Advanced Myeloid Leukemia (NCT00637052) | Pfizer | 2008-03-18 |
| A Study of LY2181308 Sodium in Patients With Relapsed or Refractory Acute Myeloid Leukemia (NCT00620321) | Eli Lilly and Company | 2008-03-01 |
| Induction, Consolidation and Intensification Therapy for Patients Younger Than 66 Years With Previously Untreated CD33 Positive Acute Myeloid Leukemia (AML) (NCT00909168) | University Hospital, Udine, Italy | 2008-03-01 |
| Observational Study of Iron Overload in Stem Cell Transplantation (NCT00954720) | Dana-Farber Cancer Institute | 2008-03-01 |
| Busulfan, Melphalan, and Fludarabine With Peri-transplant Palifermin, Followed by a T-Cell Depleted Hematopoietic Stem Cell Transplant From HLA Matched or Mismatched Related or Unrelated Donors in Patients With Advanced Myelodysplastic Syndromes (MDS) and Acute Myeloid Leukemia (AML) (NCT00629798) | Memorial Sloan Kettering Cancer Center | 2008-02-12 |
| Adding Lomustine to Chemotherapy in Older Patients With Acute Myelogenous Leukemia (AML), and Allogeneic Transplantation for Patients From 60 to 65 Years Old (NCT00590837) | University Hospital, Bordeaux | 2008-02-01 |
| Transplantation of Umbilical Cord Blood Following Chemotherapy for Blood Cancers (NCT00539656) | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | 2007-12-20 |
| Efficacy Study of Oral Sapacitabine to Treat Acute Myeloid Leukemia in Elderly Patients (NCT00590187) | Cyclacel Pharmaceuticals, Inc. | 2007-12-01 |
| Clofarabine, Cytarabine, and G-CSF in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia (NCT00602225) | University of Washington | 2007-12-01 |
| Combination of Nilotinib (AMN107) and RAD001 in Patients With Acute Myeloid Leukemia (NCT00762632) | Technical University of Munich | 2007-12-01 |
| A Randomized Study of Gemtuzumab Ozogamicin (GO) With Daunorubicine and Cytarabine in Untreated Acute Myeloid Leukemia (AML) Aged of 50-70 Years Old (NCT00927498) | Acute Leukemia French Association | 2007-12-01 |
| Clinical Factors Associated With the Development of Severe Sepsis in Patients Being Treated for Acute Myeloid Leukemia (NCT00806325) | Ohio State University | 2007-11-01 |
| Clofarabine, Cytarabine, and Thymoglobulin for Allogeneic Transplantation (NCT00593645) | Washington University School of Medicine | 2007-11-01 |
| A Study Evaluating the Effects of CLAG With Gleevec in Refractory or Relapsed Acute Myeloid Leukemia (NCT00594555) | University of Cincinnati | 2007-11-01 |
| Safety and Tolerability Study of Voreloxin and Cytarabine Combination in Acute Myeloid Leukemia in Humans (NCT00541866) | Sunesis Pharmaceuticals | 2007-10-06 |
| Efficacy and Safety Study of StemEx®, to Treat Subjects With High Risk Hematologic Malignancies, Following Myeloablative Therapy (NCT00469729) | Gamida Cell -Teva Joint Venture Ltd. | 2007-10-01 |
| Reduction of Cord Blood Transplantation Toxicity in Patients With Acute Myeloid Leukemia (NCT00797758) | Assistance Publique - Hôpitaux de Paris | 2007-10-01 |
| Phase I-II Study of Idarubicin, Cytarabine, and Sorafenib (BAY43-9006) (NCT00542971) | M.D. Anderson Cancer Center | 2007-10-01 |
| Cytarabine in Combination With Arsenic Trioxide vs. Cytarabine Alone in Elderly Patients With Acute Myeloid Leukemia (NCT00513305) | Cephalon | 2007-10-01 |
| Efficacy of Gemtuzumab Ozogamycin for Patients Presenting an Acute Myeloid Leukemia (AML) With Intermediate Risk (NCT00860639) | Nantes University Hospital | 2007-10-01 |
| Phase I Dose-Escalation Trial of Clofarabine Followed by Escalating Doses of Fractionated Cyclophosphamide in Children With Relapsed or Refractory Acute Leukemias (NCT00852709) | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | 2007-09-01 |
| A Study of Lintuzumab (SGN-33) in Combination With Low Dose Cytarabine in Patients 60+ Years With AML (NCT00528333) | Seagen Inc. | 2007-09-01 |
| Phase 2 Haplotype Mismatched HSCT in Patients With Hematological Malignancies (NCT00593554) | Sherif S. Farag | 2007-08-07 |
| Trial of PXD101 (Belinostat) in Combination With Idarubicin to Treat AML Not Suitable for Standard Intensive Therapy (NCT00878722) | Valerio Therapeutics | 2007-08-01 |
| Monitoring Minimal Residual Disease of Patients With Acute Myelogenous Leukemia or High Grade Myelodysplastic Syndrome (NCT01311258) | University of Rochester | 2007-08-01 |
| Combination of GTI-2040 and Cytarabine in the Treatment of Refractory and Relapsed Acute Myeloid Leukemia (AML) (NCT00565058) | Aptose Biosciences Inc. | 2007-08-01 |
| Phase I Epigenetic Priming Using Decitabine With Induction Chemotherapy in AML (NCT00538876) | Weill Medical College of Cornell University | 2007-07-01 |
| Study With Intravenous Busulfan And Fludarabine Myeloablative Conditioning Regimen For HLA Identical Sibling Donor HSCT (NCT01683123) | Grupo Espanol de trasplantes hematopoyeticos y terapia celular | 2007-07-01 |
| Timed-Sequential Induction in CBF-AML (NCT00428558) | Assistance Publique - Hôpitaux de Paris | 2007-07-01 |
| Oxaliplatin, Fludarabine, and Cytarabine in Acute Myeloid Leukemia (AML) or High-Risk Myelodysplastic Syndromes (MDS) (NCT00480987) | M.D. Anderson Cancer Center | 2007-07-01 |
| Modified-FLAI Induction and Consolidation Chemotherapy in Elderly Patient With Acute Myeloid Leukemia (AML) (NCT01247493) | Seoul National University Hospital | 2007-06-01 |
| Treosulfan-based Conditioning for Transplantation in AML/MDS (NCT00491634) | Dr. Avichai Shimoni MD | 2007-06-01 |
| Intermittent Liposomal Amphotericin B Primary Prophylaxis (NCT00451711) | Bayside Health | 2007-05-01 |
| Lenalidomide in Acute Leukemias and Chronic Lymphocytic Leukemia. (NCT00466895) | Leslie Andritsos | 2007-04-01 |
| Collecting and Storing Tissue From Young Patients With Cancer (NCT00898755) | Children's Oncology Group | 2007-03-05 |
| Study to Assess the Safety, Tolerability, and Efficacy of Tipifarnib Plus Bortezomib in the Treatment of Acute Myeloid Leukemia (NCT00510939) | University of Bologna | 2007-03-01 |
| Intraosseous Infusion of Unrelated Cord Blood Grafts (NCT00967525) | Emory University | 2007-03-01 |
| A Safety and Tolerability Extension Trial Assessing Repeated Dosing of Anti-KIR (1-7F9) Human Monoclonal Antibody in Patients With Acute Myeloid Leukaemia (NCT01256073) | Innate Pharma | 2007-02-01 |
| A Phase I Study of AC220 in Patients With Relapsed/Refractory Acute Myeloid Leukemia Regardless of FLT3 Status (NCT00462761) | Daiichi Sankyo | 2007-01-01 |
| Structural Imaging and Cognitive Functions in Adult Stem Cell Transplant Recipients Treated With Chemotherapy Alone or in Combination With Radiotherapy (NCT00606216) | Memorial Sloan Kettering Cancer Center | 2007-01-01 |
| Standard Idarubicin and Cytarabine for the Treatment of Acute Myeloid Leukemia (AML) (NCT00422591) | M.D. Anderson Cancer Center | 2006-12-01 |
| Decitabine as Maintenance Therapy After Standard Therapy in Treating Patients With Previously Untreated Acute Myeloid Leukemia (NCT00416598) | National Cancer Institute (NCI) | 2006-11-15 |
| Autologous Cytokine-induced Killer Cell Adoptive Immunotherapy for Acute Myeloid Leukemia and Myelodysplastic Syndrome (NCT00394381) | Singapore General Hospital | 2006-10-01 |
| A Study of Clofarabine for Older Patients With Newly Diagnosed Acute Myelogenous Leukemia (AML) (CLASSIC II) (NCT00373529) | Genzyme, a Sanofi Company | 2006-10-01 |
| Chronic Graft-versus-host Disease (cGvHD) Prophylaxis With or Without ATG Prior to Stem Cell Transplantation (SCT) From HLA-identical Siblings in Patients With Acute Leukemia (NCT00678275) | Universitätsklinikum Hamburg-Eppendorf | 2006-10-01 |
| Efficacy of Sorafenib Added to Standard Primary Therapy in Elderly Patients With Newly Diagnosed AML (NCT00373373) | University Hospital Muenster | 2006-09-01 |
| Busulfan, Fludarabine, Clofarabine With Allogeneic Stem Cell Transplantation for Acute Myeloid Leukemia (NCT00469014) | M.D. Anderson Cancer Center | 2006-09-01 |
| Study to Assess the Safety of Escalating Doses of AT9283, in Patients With Leukemias (NCT00522990) | Astex Pharmaceuticals, Inc. | 2006-09-01 |
| Allogeneic Cytokine-induced Killer Immunotherapy for Relapse After Allogeneic Marrow Transplant for Haematological Malignancies (NCT00460694) | Singapore General Hospital | 2006-08-01 |
| Study of Reduced Toxicity Myeloablative Conditioning Regimen for Cord Blood Transplantation in Pediatric AML (NCT00887042) | The Korean Society of Pediatric Hematology Oncology | 2006-06-01 |
| DNR and AraC Combined to Fractionated Mylotarg® in Patients With First Relapse of AML (NCT02182596) | Acute Leukemia French Association | 2006-06-01 |
| Safety and Anti-Disease Activity of CHR-2797 (Tosedostat) in Elderly and/or Treatment Refractory Patients With Acute Myeloid Leukemia (AML) and Multiple Myeloma (MM) (NCT00689000) | Chroma Therapeutics | 2006-05-01 |
| Safety, Efficacy and Pharmacokinetics of an Antifungal in Patients Undergoing Chemotherapy (NCT00413439) | Basilea Pharmaceutica | 2006-05-01 |
| Study of XL999 in Patients With Acute Myeloid Leukemia (AML) (NCT00322673) | Symphony Evolution, Inc. | 2006-05-01 |
| Microtransplantation in Older Patients With Acute Myeloid Leukemia (NCT02831192) | The Affiliated Hospital of the Chinese Academy of Military Medical Sciences | 2006-05-01 |
| Study of Immune Response Modifier in the Treatment of Hematologic Malignancies (NCT00276159) | Masonic Cancer Center, University of Minnesota | 2006-01-01 |
| Nebulized Liposomal Amphotericin B Ambisome for Prophylaxis of Invasive Pulmonary Aspergillosis (NCT00391014) | PETHEMA Foundation | 2006-01-01 |
| High-dose Cytarabine and Survival in AML (NCT01034839) | University of Sao Paulo General Hospital | 2006-01-01 |
| Umbilical Cord Blood Transplant, Cyclophosphamide, Fludarabine, and Total-Body Irradiation in Treating Patients With Hematologic Disease (NCT00719888) | Fred Hutchinson Cancer Center | 2005-11-18 |
| Dasatinib as Therapy for Myeloproliferative Disorders (MPDs) (NCT00255346) | M.D. Anderson Cancer Center | 2005-11-15 |
| Trial of Decitabine in Patients With Acute Myeloid Leukemia (NCT00260832) | Eisai Inc. | 2005-11-01 |
| A Safety Study of Lintuzumab in Patients With Acute Myeloid Leukemia and Myelodysplastic Syndrome (NCT00283114) | Seagen Inc. | 2005-11-01 |
| Treatment of Hematologic Malignancies With Single-Unit or Double-Unit Cord Blood Transplantation (NCT00328237) | Colorado Blood Cancer Institute | 2005-11-01 |
| Natural Killer (NK) Cell Transplantation for AML (NCT00187096) | St. Jude Children's Research Hospital | 2005-09-01 |
| Amonafide in Combination With Cytarabine in Secondary AML (NCT00273884) | Xanthus Pharmaceuticals, Inc. | 2005-08-01 |
| Stem Cell Transplantation as Immunotherapy for Hematologic Malignancies (NCT00143559) | St. Jude Children's Research Hospital | 2005-08-01 |
| Myeloablative Umbilical Cord Blood Transplantation in Hematological Diseases (NCT00309842) | Masonic Cancer Center, University of Minnesota | 2005-07-28 |
| Combination 5-azacitidine and Gemtuzumab Ozogamicin Therapy for Treatment of Relapsed Acute Myeloid Leukemia (AML) (NCT00766116) | University of California, San Diego | 2005-07-01 |
| IV Busulfan With Allo-BMT: Study for Patients With Acute Myelogenous Leukemia and Myelodysplastic Syndrome (NCT00469144) | M.D. Anderson Cancer Center | 2005-06-01 |